Evidence mapPaperPMID 39900344Full record

GuidelineJournal of gynecologic oncology2025

Clinical practice guidelines for ovarian cancer: an update to the Korean Society of Gynecologic Oncology guidelines.

Banghyun Lee, Suk-Joon Chang, Byung Su Kwon, Joo-Hyuk Son, Myong Cheol Lim, Yun Hwan Kim, Shin-Wha Lee, Chel Hun Choi, Kyung Jin Eoh, Jung-Yun Lee and 3 more

Abstract readPractice Guideline
In one paragraph

Guideline in Journal of gynecologic oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Banghyun LeeDepartment of Obstetrics and Gynecology, Inha University Hospital, Inha University College of Medicine, Incheon, Korea.ORCID 0000-0003-1036-3828
Suk-Joon ChangDepartment of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea. drchang@ajou.ac.kr.ORCID 0000-0002-0558-0038
Byung Su KwonDepartment of Obstetrics and Gynecology, School of Medicine, Kyung Hee University Medical Center, Kyung Hee University, Seoul, Korea.ORCID 0000-0002-9586-0200
Joo-Hyuk SonDepartment of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea.ORCID 0000-0002-3712-8409
Myong Cheol LimCenter for Gynecologic Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea.ORCID 0000-0001-8964-7158
Yun Hwan KimDepartment of Obstetrics and Gynecology, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.ORCID 0000-0001-9498-2938
Shin-Wha LeeDepartment of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.ORCID 0000-0002-5088-1905
Chel Hun ChoiDepartment of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID 0000-0002-0199-6669
Kyung Jin EohDepartment of Obstetrics and Gynecology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Korea.ORCID 0000-0002-1684-2267
Jung-Yun LeeDepartment of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea.ORCID 0000-0001-7948-1350
Yoo-Young LeeDepartment of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID 0000-0001-5902-9877
Dong Hoon SuhDepartment of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.ORCID 0000-0002-4312-966X
Yong Beom KimDepartment of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seongnam, Korea.ORCID 0000-0003-1196-369X

Funding

National Cancer Center NCC-2112570-3
6 · The paper itself

Abstract

We updated the Korean Society of Gynecologic Oncology (KSGO) practice guideline for the management of ovarian cancer as version 5.1. The ovarian cancer guideline team of the KSGO published announced the fifth version (version 5.0) of its clinical practice guidelines for the management of ovarian cancer in December 2023. In version 5.0, the selection of the key questions and the systematic reviews were based on the data available up to December 2022. Therefore, we updated the guidelines version 5.0 with newly accumulated clinical data and added 5 new key questions reflecting the latest insights in the field of ovarian cancer between 2023 and 2024. For each question, recommendation was provided together with corresponding level of evidence and grade of recommendation, all established through expert consensus.

Indexed as

Carcinoma, Ovarian EpithelialOvarian NeoplasmsFemaleGynecologyHumansMedical OncologyRepublic of KoreaSocieties, MedicalHyperthermic Intraperitoneal ChemotherapyMirvetuximab SoravtansineOvarian NeoplasmsPoly(ADP-ribose) Polymerase (PARP) InhibitorPractice GuidelineRisk-educing Salpingo-oophorectomyTrastuzumab Deruxtecan

Identifiers

PMID39900344
PMCPMC11790995

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.